|
US3190884A
(en)
*
|
|
1965-06-22 |
|
Chz-chz-cn |
|
US3236852A
(en)
*
|
|
1966-02-22 |
|
Esters of g-methyl- and i,g-dimethyl.
ergoline |
|
US3249617A
(en)
*
|
|
1966-05-03 |
|
Alkylated d-lyserglc acid |
|
US3251846A
(en)
*
|
|
1966-05-17 |
|
G-dimethyosoergolenyl-b |
|
US3346580A
(en)
*
|
|
1967-10-10 |
|
Lysergic acid amides |
|
US3218323A
(en)
*
|
|
1965-11-16 |
|
Esters of i,g-dimethyl-b-ergolenyl
carbamic acid |
|
US3228939A
(en)
*
|
|
1966-01-11 |
|
Methyl and i,g-dimethyl-ergoline ii
derivatives |
|
CH344731A
(de)
*
|
1956-05-18 |
1960-02-29 |
Sandoz Ag |
Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
|
|
US3131189A
(en)
*
|
1961-10-16 |
1964-04-28 |
Pure Oil Co |
Preparation of quaternary ammonium betaine salts
|
|
AT251200B
(de)
*
|
1962-07-13 |
1966-12-27 |
Farmaceutici Italia |
Verfahren zur Herstellung neuer Derivate von Dihydro-D-lysergsäureamid und 1-Methyl-dihydro-D-lysergsäureamid
|
|
GB1067513A
(en)
*
|
1963-08-29 |
1967-05-03 |
Sandoz Ltd |
Derivatives of ergolene
|
|
US3239530A
(en)
*
|
1964-01-13 |
1966-03-08 |
Sandoz Ltd |
Process for lysergic acid hydrazides
|
|
CH469006A
(de)
*
|
1965-07-07 |
1969-02-28 |
Sandoz Ag |
Verfahren zur Herstellung neuer synthetischer Alkaloide
|
|
US3681497A
(en)
*
|
1966-06-07 |
1972-08-01 |
Spofa Vereinigte Pharma Werke |
Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide
|
|
CH508628A
(de)
*
|
1968-06-25 |
1971-06-15 |
Sandoz Ag |
Verfahren zur Herstellung neuer heterocyclischer Verbindungen
|
|
US3846433A
(en)
*
|
1969-05-06 |
1974-11-05 |
Sandoz Ltd |
Process for preparing ergot alkaloids
|
|
CH517099A
(de)
*
|
1969-06-20 |
1971-12-31 |
Sandoz Ag |
Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
|
|
US4165376A
(en)
*
|
1971-01-29 |
1979-08-21 |
Lake Shore Roentgenology, Ltd. |
Treatment of the acute after-effects resulting from alcohol ingestion
|
|
CH573937A5
(de)
*
|
1971-08-05 |
1976-03-31 |
Spofa Vereinigte Pharma Werke |
|
|
US3875167A
(en)
*
|
1972-05-26 |
1975-04-01 |
Research Corp |
Synthesis of thalicarpine
|
|
DE2330912C3
(de)
*
|
1972-06-22 |
1979-01-11 |
Societa Farmaceutici Italia S.P.A., Mailand (Italien) |
Verfahren zur Herstellung von Bromergolinverbindungen
|
|
US3904633A
(en)
*
|
1973-02-05 |
1975-09-09 |
Richter Gedeon Vegyeszet |
Lysergic amides
|
|
USRE30219E
(en)
*
|
1974-12-06 |
1980-02-19 |
Eli Lilly And Company |
Method of preparing 8,8-disubstituted-6-methylergolines and related compounds
|
|
USRE30218E
(en)
*
|
1974-12-06 |
1980-02-19 |
Eli Lilly And Company |
8,8-Disubstituted-6-methylergolines and related compounds
|
|
US3968111A
(en)
*
|
1974-12-06 |
1976-07-06 |
Eli Lilly And Company |
8,8-Disubstituted-6-methylergolines and related compounds
|
|
US4138565A
(en)
*
|
1975-05-31 |
1979-02-06 |
Sandoz Ltd. |
Stable solutions and processes for their preparation
|
|
YU40004B
(en)
*
|
1977-07-21 |
1985-06-30 |
Lek Tovarna Farmacevtskih |
Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
|
|
DD146460A1
(de)
*
|
1979-11-14 |
1981-02-11 |
Reni Bartsch |
Verfahren zur herstellung 1-benzylierter ergometrinderivate
|
|
US4315937A
(en)
*
|
1979-11-28 |
1982-02-16 |
Sandoz Ltd. |
Ergots and their use in treating minimal brain dysfunction
|
|
US4526892A
(en)
*
|
1981-03-03 |
1985-07-02 |
Farmitalia Carlo Erba, S.P.A. |
Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
|
|
CS231214B1
(en)
*
|
1982-03-12 |
1984-10-15 |
Antonin Cerny |
Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea
|
|
EP0091652B1
(de)
*
|
1982-04-13 |
1986-02-26 |
FARMITALIA CARLO ERBA S.p.A. |
Ergolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
|
|
US4563461A
(en)
*
|
1983-03-10 |
1986-01-07 |
Eli Lilly And Company |
Selective method for blocking 5HT2 receptors
|
|
FR2584721B1
(fr)
*
|
1985-07-11 |
1987-10-02 |
Rhone Poulenc Sante |
Procede de preparation des derives n-methyles du dihydrolysergate de methyle ou du methoxylumilysergate de methyle
|
|
US4772709A
(en)
*
|
1985-10-01 |
1988-09-20 |
Eli Lilly And Company |
Process of making ketoalkanol esters of dihydrolysergic acid
|
|
US4968802A
(en)
*
|
1985-10-01 |
1990-11-06 |
Eli Lilly And Company |
Process of making alkoxy cycloalkanol esters of dihydrolysergic acid
|
|
US4713384A
(en)
*
|
1985-10-01 |
1987-12-15 |
Eli Lilly And Company |
Selective method for blocking 5HT2 receptors
|
|
US4810710A
(en)
*
|
1985-10-01 |
1989-03-07 |
Eli Lilly And Company |
4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine
|
|
US4847261A
(en)
*
|
1985-10-01 |
1989-07-11 |
Eli Lilly And Company |
Alkoxy cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonists properties
|
|
US4906639A
(en)
*
|
1985-10-01 |
1990-03-06 |
Eli Lilly And Company |
Cycloalkanol esters of dihydrolysergic acid
|
|
US4713385A
(en)
*
|
1985-10-01 |
1987-12-15 |
Eli Lilly And Company |
Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
|
|
US4939258A
(en)
*
|
1985-10-01 |
1990-07-03 |
Eli Lilly And Company |
Cycloalkanol esters of dihydrolysergic acid
|
|
US4683236A
(en)
*
|
1985-10-01 |
1987-07-28 |
Eli Lilly And Company |
Cycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonists
|
|
US4820713A
(en)
*
|
1985-10-01 |
1989-04-11 |
Eli Lilly And Company |
Ketoalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
|
|
US4762842A
(en)
*
|
1985-10-01 |
1988-08-09 |
Eli Lilly And Company |
Selective method for blocking 5HT2 receptors
|
|
US4714704A
(en)
*
|
1985-10-01 |
1987-12-22 |
Eli Lilly And Company |
Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
|
|
US4845224A
(en)
*
|
1985-10-01 |
1989-07-04 |
Eli Lilly And Company |
Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties
|
|
US4704395A
(en)
*
|
1985-12-20 |
1987-11-03 |
Eli Lilly And Company |
Cyclic ether esters of 2-substituted-6-(substituted and unsubstituted) dihydrolysergic acid useful as 5HT receptor antagonists
|
|
US4704396A
(en)
*
|
1985-12-20 |
1987-11-03 |
Eli Lilly And Company |
Phenacyl esters of 1-substituted-6-(substituted and unsubstituted) dihydrolysergic acids useful as 5HT receptor antagonists
|
|
US4683237A
(en)
*
|
1985-12-20 |
1987-07-28 |
Eli Lilly And Company |
Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
|
|
US4874766A
(en)
*
|
1986-09-22 |
1989-10-17 |
Janssen Pharmaceutica N.V. |
Method of promoting wound-healing
|
|
US4981859A
(en)
*
|
1987-06-15 |
1991-01-01 |
|
Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
|
|
US4931447A
(en)
*
|
1987-06-15 |
1990-06-05 |
Eli Lilly And Company |
Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
|
|
US4798834A
(en)
*
|
1987-08-31 |
1989-01-17 |
Eli Lilly And Company |
Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
|
|
US5843682A
(en)
*
|
1995-11-20 |
1998-12-01 |
Boehringer Mannheim Corporation |
N-1-carboxyalkyl derivatives of LSD
|
|
US6207396B1
(en)
|
1995-11-20 |
2001-03-27 |
Microgenics Corporation |
Immunoassay reagents and methods for determination of LSD and LSD metabolites
|
|
DE10212564B4
(de)
*
|
2002-03-12 |
2007-04-19 |
Neurobiotec Gmbh |
1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
|
|
IN2012DN04858A
(de)
*
|
2009-12-23 |
2015-09-25 |
Map Pharmaceuticals Inc |
|
|
KR20140042868A
(ko)
|
2011-06-23 |
2014-04-07 |
맵 파마슈티컬스, 인코포레이티드 |
신규한 플루오로에르골린 유사체
|
|
SG10201509139QA
(en)
|
2011-12-19 |
2015-12-30 |
Map Pharmaceuticals Inc |
Novel iso-ergoline derivatives
|
|
CA2859175A1
(en)
|
2011-12-21 |
2013-06-27 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|